Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential …

Connecting Minds. Advancing Light. SPIE is the international society for optics and photonics. We bring together engineers, scientists, students, and industry leaders, strengthening the global optics and photonics community through conferences, publications, and professional development. Inspired by the transformative power of photonics to enhance life around the globe, over the past five years SPIE has contributed more than $24 million to the international optics community. Research Publications, Conferences, Education, Scholarships, Exhibitions, Industry, Optics, Photonics, Not-for-profit, Science, Engineering, Light-based research, International Society, Photonics West, Outreach, Membership Society, and Equity, Diversity, and Inclusion

Sectors: Research

#WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen …

Sectors: Biotechnology

There's always a way to make life better. Over the past decade we have transformed into a focused leader in health technology. At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. We aim to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities. We see healthcare as a connected whole. Helping people to live healthily and prevent disease. Giving clinicians the tools they need to make a precision diagnosis and deliver personalized treatment. Aiding the patient's recovery at home in the community. All supported by a seamless flow of data. …

Sectors: Electricals